Senior insider sale
Chief Discovery Officer at MAPLIGHT THERAPEUTICS, INC. — senior position signals high conviction
$1.44M
48.74K shares
What this filing means
KREITZER ANATOL plans to sell 48.74K shares of MAPLIGHT THERAPEUTICS, INC. valued at approximately $1.44M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/27/2026ACC: 0001950047-26-003784
Officer· Chief Discovery Officer
Since Feb 2026
48.74K
Shares to sell
$1.44M
Approx. market value
45.42K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
7/5/2024
45.42KTotal acquired45.42K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/5/2024 | Restricted Stock Units N/A | 45.42K | — |
| Total | 45.42K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
3.32K
Market value
$88.2K
4/15/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
45.42K
Market value
$1.35M
4/27/2026
Total
Units
48.74K
Value
$1.44M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/15/2026 | 3.32K | $88.2K | — | Completed |
| Planned — Approximate Date | ||||
4/27/2026 | 45.42K | $1.35M | NASDAQ | Planned |
| Total | 48.74K | $1.44M | ||